Catheter ablation for atrial fibrillation in a subset of patients with concomitant hypertension

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 2

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Hypertension

ISSN

2220-3168

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Hypertens. May 23, 2015; 5(2): 98-103
Published online May 23, 2015. doi: 10.5494/wjh.v5.i2.98

Table 1 Anti-hypertensive drugs taken by patients before and after catheter ablation procedures

No. of patients	Anti-hypertensive agents
7	ACE inhibitor
7	Calcium channel blockers
2	Beta blockers
1	Angiotensin 2 receptor blocker
6	ACE inhibitor, beta blocker
3	Calcium channel blocker, angiotensin 2 receptor blocker
2	ACE inhibitor blocker. Calcium channel blocker
2	ACE inhibitor, diuretic
1	Calcium channel blocker, beta blocker, diuretic
1	Calcium channel blocker, beta blocker
1	ACE inhibitor, calcium channel blocker, diuretic

Citation: Sharma T, Scherlag BJ, Nakagawa H, Jackman WM, Lazzara R, Po SS. Catheter ablation for atrial fibrillation in a subset of patients with concomitant hypertension. World J Hypertens 2015; 5(2): 98-103
URL: https://www.wjgnet.com/2220-3168/full/v5/i2/98.htm
DOI: https://dx.doi.org/10.5494/wjh.v5.i2.98

Sharma T, Scherlag BJ, Nakagawa H, Jackman WM, Lazzara R, Po SS. Catheter ablation for atrial fibrillation in a subset of patients with concomitant hypertension. World J Hypertens 2015; 5(2): 98-103 [DOI: 10.5494/wjh.v5.i2.98]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.